ArticleInvestigational new drugs2016

Molecular mode of action of NKP-1339 - a clinically investigated ruthenium-based drug - involves ER- and ROS-related effects in colon carcinoma cell lines.

Lea S Flocke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.